. Comparison of thrombin versus thromboplastin D as a method to obtain serum from plasma. (A) Both factors induced the coagulation of plasma. However, thrombin tended to produce a more homogeneous clot size. (B) Thromboplastin D and thrombin, diluted in PBS to the concentration used in plasma samples, were analyzed for CD81, mid-region tau, and p181-tau. Neither thromboplastin D nor thrombin produced a CD81 signal. However, thromboplastin D yielded very high p181 and mid-region tau signals even when diluted 100-fold, whereas thrombin did not produce a significant signal in either assay.
. Increasing incubation time or the amount of streptavidin resin ensures maximal capture of biotinylated anti-L1CAM. (A) Schematic of the protocol used to determine the optimal concentration of streptavidin resin and incubation time to effectively capture biotinylated anti-L1CAM antibody. Four µg of L1CAM-biotin antibody in 500 µl of PBS was incubated with increasing amounts of streptavidin resin (15 µl, 30 µl and 60 µl) for increasing times (0.5 hour, 4 hours, or overnight). Streptavidin resin was pelleted and supernatants were tested for the presence of free biotinylated anti-L1CAM. (B) Streptavidin coated MSD plates were used to capture biotinylated L1CAM (blue IgG), and this was detected using a SULFO-TAG anti-mouse antibody (red IgG). (C) Comparison of the relative amounts of free-floating biotinylated anti-L1CAM antibody detected when different amounts of streptavidin resin and different incubation times were tested. . Quantification of CD81 levels in blood-derived neuronal exosome lysates from 40 donors. CD81 levels were determined on two different days; the first experiment (Day 1) was performed on undiluted samples and the second experiment (Day 2) was performed on samples diluted 1.8-fold. Samples denoted 'Plasma A' and 'Plasma B' served as internal plate controls.
